Abstract
Background:Postpartum hemorrhage (PPH) is a leading cause of maternal mortality and morbidity. The WOMAN trial showed that tranexamic acid (TXA) reduces death due to bleeding in women with PPH. To determine whether TXA has pro-thrombotic effects in women with PPH, we measured endogenous thrombin potential (ETP), coagulation factors V, VIII, von Willebrand (vW), fibrinogen, D-Dimers and platelet function.Methods: We conducted a sub-study within the WOMAN trial, an international randomized, parallel-group, double blind, placebo-controlled trial. Women with primary PPH were randomly allocated to receive 1 gram of tranexamic acid or matching placebo. Baseline blood samples were collected just prior to the first dose and a follow up sample was collected 30±15 minutes afterwards. We compared before and after changes in coagulation parameters between treatment groups using repeated measurement ANOVA. Change in ETP was the primary outcome. We did an intention-to-treat analysis using ANCOVA with adjustment for baseline and the time interval between the blood samples.Findings:A total of 187 patients were randomized to receive TXA (n=93) or matching placebo (n=94). Six patients were excluded due to incomplete data. The reduction in ETP from baseline to follow up was 43.2 nM*min (95%CI, -16.6 to 103.1) in the TXA group and 4.6 nM*min (95%CI, -51.4 to 60.6) in the placebo group. The difference was not statistically significant (95%CI, -42.9 to 120). There were no significant effects of TXA treatment on any other parameters (ADPtest, TRAPtest, coagulation factors activity, fibrinogen levels, D-Dimer level).Conclusion:We found no evidence that tranexamic acid treatment for PPH has substantial pro-coagulant effects. However, larger studies are needed to confirm or refute more modest effects.Trial registration:ISRCTN76912190(initially registered 10/12/2008, WOMAN-ETAPlat included on 28/10/2013) andNCT00872469(initially registered 31/03/2009, WOMAN-ETAPlat included on 28/10/2013).
Funder
Erasmus Mundus program - ERAWEB
Department of Health
Wellcome Trust
Subject
General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)
Reference29 articles.
1. Temporal trends of postpartum haemorrhage in Switzerland: a 22-year retrospective population-based cohort study.;A Kaelin Agten;Swiss Med Wkly.,2017
2. Tranexamic Acid for the Management of Obstetric Hemorrhage.;L Pacheco;Obstet Gynecol.,2017
3. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.;H Shakur;Lancet.,2010
4. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial.;Lancet.,2017
5. Updated WHO Recommendation on Tranexamic Acid for the Treatment of Postpartum Haemorrhage
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献